IL17A and systemic sclerosis: The frequency of peripheral blood TIM-1+ IL-10+ Breg is decreased in SSc patients compared with healthy controls, with a further defective ability to suppress CD4+ T-cell activation and inflammatory cytokine secretion (IFN-γ, TNF-α, IL-17) (27).